Company / Return on Assets (ROA)
IONIS PHARMACEUTICALS INC Return on Assets (ROA) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-10.8%
FY2025
5-year range
-15.1% / 10.7%
FY2021-FY2025
Trend
+28.4%
vs FY2024
Sector context
#82 of 213
Health Care
What the data says
At -10.8%, IONIS PHARMACEUTICALS INC's return on assets (roa) ranks #82 of 213 in the Health Care sector. Return on Assets (ROA) returned to growth in FY2025 after 4 years of decline, reaching -10.8%.
Based on SEC 10-K filings.
-10.8% in FY2025 with a 5-year CAGR of -22.3%.
Improved from -12.3% to -10.8% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -0.2pp
- 5-Year Change
- -22.3pp
- 10-Year Change
- -
Sector benchmark
#82 of 213 in Health CareTop 38% of 213This company -10.8% Sector average -24.2%
▼
+55.2% above sector average
Key checks
Key Insights
- In FY2025, return on assets (roa) increased 28.4% year-over-year.
- Currently 13.3pp above the Health Care sector average.
- Peak return on assets (roa) was recorded in FY2020.
- Lowest return on assets (roa) in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -10.8% | +28.4% |
| FY2024 | -15.1% | -23.3% |
| FY2023 | -12.3% | -15.1% |
| FY2022 | -10.6% | -199.9% |
| FY2021 | 10.7% | -7.0% |
| FY2020 | 11.5% | +114400.0% |
| FY2019 | 0.0% | +100.4% |
| FY2018 | -2.3% | -7633.3% |
| FY2017 | 0.0% | +100.5% |
| FY2016 | -6.6% | +28.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026